Stay updated on Amivantamab in Adenoid Cystic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.0 to v3.6.3, signaling a newer version of the page template or content.
    Difference
    0.1%
    Check dated 2026-06-30T01:22:38.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment note 'No longer looking for participants'; standardized the label from 'Intervention / Treatment' to 'Intervention/Treatment', and updated the revision tag from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T18:57:11.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the page documentation.
    Difference
    0.1%
    Check dated 2026-06-08T17:12:08.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page metadata.
    Difference
    0.1%
    Check dated 2026-05-18T04:00:13.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now includes posted results with dates and the associated outcome measures, safety data, and QoL, plus links to the Study Protocol and Statistical Analysis Plan, reflecting updated documentation for the study record.
    Difference
    2%
    Check dated 2026-05-11T01:56:08.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A new citation was added for Amivantamab in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial (JAMA Otolaryngol Head Neck Surg, 2026 Apr 1). The prior online-ahead-of-print citation (Feb 26, 2026) was removed.
    Difference
    0.1%
    Check dated 2026-05-04T01:16:55.000Z thumbnail image

Stay in the know with updates to Amivantamab in Adenoid Cystic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.